Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 117

Aulton achieves $232m series B

The Nio Capital and SB Energy-backed EV battery exchange platform’s latest round was co-led by Sinopec Capital’s Enze Fund and brought its valuation to over $1bn.

Sep 30, 2021

Andela drafts SoftBank for $200m series E

Software developer-focused recruitment firm Andela was valued at $1.5bn in a series E round led by Softbank Vision Fund 2.

Sep 30, 2021

Betterment bags $160m in series F round

Citi and Aflac have contributed to a series F debt and equity round for the digital investment adviser which is now valued at almost $1.3bn.

Sep 30, 2021

Vedantu makes grade to raise $100m

The TAL Education-backed online tutoring platform developer achieved unicorn status with a round hiking its overall funding to about $295m.

Sep 30, 2021

Expansion Therapeutics executes $80m series B

Sanofi Ventures and Novartis Venture Fund have returned to back small molecule drug developer Expansion Therapeutics' series B round.

Sep 30, 2021

Wayspring rebrands with $75m round

Addiction management services provider Wayspring boosted its overall funding to about $100m in a round featuring Centene, Caresource and existing investor Blue Venture Fund.

Sep 30, 2021

Hedvig handles $45m in series B funding

Commerzbank and Axel Johnson helped the online insurance provider reach $68m in overall funding by backing its series B round.

Sep 30, 2021

NovaSignal detects $37m in series C1 round

The TigerMed-backed neural diagnostics technology developer has topped up its coffers in a round co-led by Alpha Edison and Reimagined Ventures.

Sep 30, 2021

Exotel calls in $35m of series C funding

Sistema co-led a new round for the customer engagement platform developer fresh off the latter's merger with virtual call centre operator Ameyo.

Sep 30, 2021

Kytopen constructs $30m series A

Alexandria Venture Investments participated in a $30m round for the gene therapy technology developer, which will use the capital to expand its partnerships.

Sep 30, 2021
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here